Giuliana Grossi

A Maui Derm 2026 session explored advancements in pediatric dermatology, emphasizing precision medicine and targeted therapies for children.

Speakers delved into innovative strategies in skin tumor management, focusing on chemotherapies, patient risk assessment, and evolving treatment protocols.

Experts discuss groundbreaking therapies in dermatology at Maui Derm 2026, addressing complex skin diseases and enhancing patient care with innovative treatments.

Maui Derm 2026 showcases groundbreaking clinical trial data and innovative strategies in dermatology.

Research reveals that socioeconomic status significantly impacts survival rates in young adults with metastatic colorectal cancer, emphasizing the need for health equity initiatives.

Sleep-focused TNX-102 SL delivered significant benefits in a phase 3 fibromyalgia study.

As the FY26 budget is being negotiated, Jennifer Snow, MPA, of NAMI, emphasizes that funds must be directed to programs as Congress intends.

NAMI's National Director of Government Relations and Policy, Jennifer Snow, MPA, explains how advocates rallied in support of mental health care.

In this week’s health equity news, ICHRAs may offer flexible health coverage options amid ACA subsidy uncertainties, and advocates rally for mental health funding stability.

The Trump administration says it will restore vital SAMHSA funding after swift advocacy from mental health supporters.

Federal grant terminations by SAMHSA threaten vital mental health and substance use services, risking lives amid rising suicide rates and addiction crises.

The latest dietary guidelines emphasize reducing processed foods, promoting whole foods, and increasing protein intake, aiming to improve public health.

As part of the deal, AbbVie is expanding its direct-to-patient offerings through the TrumpRx program.

This week's news roundup covers updates in health policy, technology, and access to pharmaceuticals.

A recent study reveals that medical debt significantly increases the risk of housing instability, highlighting urgent implications for health policy and financial security.

Johnson & Johnson partners with the Trump Administration to lower drug prices and utilize TrumpRx.com, joining a growing list of pharmaceutical companies.

This week, we look at 5 key health care changes the Trump Administration made in 2025, changes to the immunization schedule, and new research on telehealth accessibility.

New research reveals how outdoor nighttime light exposure subtly impacts sleep quality, increasing light sleep duration while affecting deep sleep in complex ways.

The CDC announced a significant change to the childhood immunization schedule that would reduce vaccine recommendations.

These are the most popular multiple myeloma articles from 2025.

Exercise enhances quality of life and sleep for those with ovarian cancer, highlighting the need for further research in supportive care.

Obstructive sleep apnea significantly worsens mental health in older adults, increasing risks of depression and psychological distress over time.

Check out the most popular stories and developments that happened in mental health care this year.

Baricitinib shows promising results for severe alopecia areata, with more than half of patients experiencing significant hair regrowth within a year.

Obstructive sleep apnea may increase Parkinson disease risk, but early CPAP treatment could significantly reduce this risk.

A look back at the breakthroughs in pulmonary fibrosis research, including FDA-approved treatments and innovative diagnostic techniques.

Trump secures new pricing deals with 9 drugmakers, advancing his effort to align US drug costs with Europe and expand direct-to-consumer purchasing.

New research reveals that quick sleep onset may lower hypertension risk, challenging traditional views on sleepiness and cardiovascular health.

Reflect on the challenges in health equity, care access, and policy shifts impacting health insurance and clinical research in 2025.

This year’s most-read articles on CKD highlighted research and insights on drug approvals, guidelines, and value-based care.